Insider Actions for ZIOPHARM Oncology Inc.
– Purchase
– Sale
1
– Number of Transactions
Date
Name
Transaction
Value
| 05/07/2019 |
James Anthony Cannon Director |
15,000 | Derivative/Non-derivative trans. at $0.7 per share. | 10,500 |
| 01/06/2019 |
Laurence James Neil Cooper Chief Executive Officer; Director |
165,178 | Derivative/Non-derivative trans. at $2.24 per share. | 369,998 |
| 01/06/2019 |
Laurence James Neil Cooper Chief Executive Officer; Director |
446,428 | Award at $0 per share. | 0 |
| 01/06/2019 |
Laurence James Neil Cooper Chief Executive Officer; Director |
337,266 | Award at $0 per share. | 0 |
| 01/06/2019 |
David M. Mauney President |
159,010 | Award at $0 per share. | 0 |
| 01/06/2019 |
Robert Hadfield General Counsel and Secretary |
117,572 | Award at $0 per share. | 0 |
| 01/06/2019 |
Kevin G. Lafond SVP, Treasurer & CAO |
37,122 | Award at $0 per share. | 0 |
| 12/31/2018 |
Laurence James Neil Cooper Chief Executive Officer; Director |
16,156 | Derivative/Non-derivative trans. at $1.87 per share. | 30,211 |
| 12/31/2018 |
Kevin G. Lafond SVP, Treasurer & CAO |
9,334 | Derivative/Non-derivative trans. at $1.87 per share. | 17,454 |
| 12/31/2018 |
Elan Z. Ezickson Director |
80,214 | Award at $0 per share. | 0 |
| 12/31/2018 |
Douglas W. Pagán Director |
40,107 | Award at $0 per share. | 0 |
| 12/30/2018 |
Laurence James Neil Cooper Chief Executive Officer; Director |
26,178 | Derivative/Non-derivative trans. at $1.66 per share. | 43,455 |
| 12/30/2018 |
Kevin G. Lafond SVP, Treasurer & CAO |
13,100 | Derivative/Non-derivative trans. at $1.66 per share. | 21,746 |
| 12/29/2018 |
Laurence James Neil Cooper Chief Executive Officer; Director |
42,920 | Derivative/Non-derivative trans. at $1.66 per share. | 71,247 |
| 12/29/2018 |
James Anthony Cannon Director |
4,315 | Derivative/Non-derivative trans. at $1.66 per share. | 7,162 |
| 12/29/2018 |
Kevin G. Lafond SVP, Treasurer & CAO |
17,667 | Derivative/Non-derivative trans. at $1.66 per share. | 29,327 |
| 05/05/2018 |
Laurence James Neil Cooper Chief Executive Officer; Director |
123,333 | Derivative/Non-derivative trans. at $4.41 per share. | 543,898 |
| 12/31/2017 |
Laurence James Neil Cooper Chief Executive Officer; Director |
16,157 | Derivative/Non-derivative trans. at $4.14 per share. | 66,889 |
| 12/31/2017 |
Caesar J. Belbel COO, CLO, and Secretary |
21,667 | Derivative/Non-derivative trans. at $4.14 per share. | 89,701 |
| 12/31/2017 |
Francois Lebel Executive Vice President R&D |
21,667 | Derivative/Non-derivative trans. at $4.14 per share. | 89,701 |
| 12/31/2017 |
Kevin G. Lafond SVP, Treasurer & CAO |
9,333 | Derivative/Non-derivative trans. at $4.14 per share. | 38,638 |
| 12/30/2017 |
Laurence James Neil Cooper Chief Executive Officer; Director |
26,178 | Derivative/Non-derivative trans. at $4.14 per share. | 108,376 |
| 12/30/2017 |
James Anthony Cannon Director |
4,301 | Derivative/Non-derivative trans. at $4.14 per share. | 17,806 |
| 12/30/2017 |
Michael Weiser Director |
6,021 | Derivative/Non-derivative trans. at $4.14 per share. | 24,926 |
| 12/30/2017 |
Caesar J. Belbel COO, CLO, and Secretary |
31,450 | Derivative/Non-derivative trans. at $4.14 per share. | 130,203 |
| 12/30/2017 |
Francois Lebel Executive Vice President R&D |
31,450 | Derivative/Non-derivative trans. at $4.14 per share. | 130,203 |
| 12/30/2017 |
Wyche Fowler Director |
6,882 | Derivative/Non-derivative trans. at $4.14 per share. | 28,491 |
| 12/30/2017 |
Kevin G. Lafond SVP, Treasurer & CAO |
13,100 | Derivative/Non-derivative trans. at $4.14 per share. | 54,234 |
| 12/30/2017 |
Murray F. Brennan Director |
6,813 | Derivative/Non-derivative trans. at $4.14 per share. | 28,205 |
| 12/29/2017 |
Laurence James Neil Cooper Chief Executive Officer; Director |
348,000 | Award at $0 per share. | 0 |
| 12/29/2017 |
James Anthony Cannon Director |
17,258 | Award at $0 per share. | 0 |
| 12/29/2017 |
Michael Weiser Director |
17,258 | Award at $0 per share. | 0 |
| 12/29/2017 |
Caesar J. Belbel COO, CLO, and Secretary |
87,000 | Award at $0 per share. | 0 |
| 12/29/2017 |
Francois Lebel Executive Vice President R&D |
116,000 | Award at $0 per share. | 0 |
| 12/29/2017 |
Wyche Fowler Director |
17,258 | Award at $0 per share. | 0 |
| 12/29/2017 |
Kevin G. Lafond SVP, Treasurer & CAO |
53,000 | Award at $0 per share. | 0 |
| 12/29/2017 |
Murray F. Brennan Director |
17,258 | Award at $0 per share. | 0 |
| 12/12/2017 |
James Anthony Cannon Director |
13,094 | Derivative/Non-derivative trans. at $4.17 per share. | 54,601 |
| 12/12/2017 |
James Anthony Cannon Director |
20,000 | Derivative/Non-derivative trans. at $2.73 per share. | 54,600 |
